Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Epizyme, Inc. (EPZM)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/16/2022 |
4
| GOLDFISCHER CARL (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Disposed/sold 13,060 shares
@ $0
Disposed/sold 8,994 shares
@ $0
Disposed/sold 3,380,951 shares
@ $0 |
|
| 08/16/2022 |
4
| Conroy Kevin T (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Disposed/sold 53,324 shares
@ $0
Disposed/sold 8,994 shares
@ $0 |
|
| 08/16/2022 |
4
| Richon Victoria (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Disposed/sold 13,614 shares
@ $0
Disposed/sold 8,994 shares
@ $0 |
|
| 08/16/2022 |
4
| MOTT DAVID M (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Unknown transaction of 215,494 shares
@ $0
Disposed/sold 8,994 shares
@ $0
Unknown transaction of 106,959 shares
@ $0 |
|
| 08/16/2022 |
4
| BEVERIDGE, ROY A (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Disposed/sold 20,341 shares
@ $0
Disposed/sold 25,696 shares
@ $0 |
|
| 08/16/2022 |
4
| Agarwal Shefali (See Remarks) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Disposed/sold 179,247 shares
@ $0
Disposed/sold 107,292 shares
@ $0 |
|
| 08/16/2022 |
4
| Korn Jerald (COO) has filed a Form 4 on Epizyme, Inc. |
| 08/16/2022 |
4
| Legorreta Pablo G. (10% Owner) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Unknown transaction of 31,933,334 shares
@ $0
Disposed/sold 8,060 restricted stock units
@ $0
Disposed/sold 8,994 restricted stock units
@ $0 |
|
| 08/16/2022 |
4
| Beaulieu Joseph (See Remarks) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Disposed/sold 30,181 shares
@ $0
Disposed/sold 21,895 shares
@ $0 |
|
| 08/16/2022 |
4
| BATE KENNETH (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Disposed/sold 8,060 shares
@ $0
Disposed/sold 8,994 shares
@ $0 |
|
| 08/16/2022 |
4
| Kutok Jeffery (Chief Scientific Officer) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Disposed/sold 39,046 shares
@ $0
Disposed/sold 81,021 shares
@ $0 |
|
| 08/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/16/2022 |
4
| Bogle Grant C. (President and CEO) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Disposed/sold 84,170 shares
@ $0
Disposed/sold 175,000 shares
@ $0 |
|
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2022 |
4
| BEVERIDGE, ROY A (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 8,928 shares
@ $1.47, valued at
$13.1k
|
|
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2022 |
4
| Richon Victoria (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 8,994 shares
@ $0
Granted 41,006 options to buy
@ $0.56, valued at
$23k
|
|
| 05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2022 |
4
| BEVERIDGE, ROY A (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 8,994 shares
@ $0
Granted 41,006 options to buy
@ $0.56, valued at
$23k
|
|
| 04/13/2022 |
4
| Kutok Jeffery (Chief Scientific Officer) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Sold 2,741 shares
@ $0.9, valued at
$2.5k
|
|
| 04/04/2022 |
4
| Korn Jerald (COO) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 800,000 options to buy
@ $1.14, valued at
$912k
|
|
| 04/01/2022 |
4
| BEVERIDGE, ROY A (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 11,413 shares
@ $1.15, valued at
$13.1k
|
|
| 04/01/2022 |
4
| MOTT DAVID M (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 20,653 shares
@ $1.15, valued at
$23.8k
|
|
| 04/01/2022 |
4
| Conroy Kevin T (Director) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 13,043 shares
@ $1.15, valued at
$15k
|
|
| 03/21/2022 |
4
| Bogle Grant C. (See Remarks) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 800,000 options to buy
@ $1.39, valued at
$1.1M
|
|
| 03/21/2022 |
4
| Beaulieu Joseph (See Remarks) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 2,331 shares
@ $1.2665, valued at
$3k
Granted 300,000 options to buy
@ $1.39, valued at
$417k
|
|
| 03/21/2022 |
4
| Kutok Jeffery (Chief Scientific Officer) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 380,000 options to buy
@ $1.39, valued at
$528.2k
|
|
|
|
|